VHL and nonpapillary renal cell carcinoma: In addition, as a highly frequently mutated gene in ccRCC, VHL has been confirmed as the key indicator for evaluating cancer metastasis and therapeutic efficacy (Yao et al., 2017; Hsieh et al., 2018).